We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$1.3B
Cap. Flow
+$1.27B
Cap. Flow %
62.75%
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,161
Increased
164
Reduced
123
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 6.93%
2 Consumer Discretionary 6.9%
3 Healthcare 6.22%
4 Industrials 4.3%
5 Technology 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCN
2126
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$79K ﹤0.01%
+10,093
New +$79K
TOVX icon
2127
Theriva Biologics
TOVX
$10.6M
$79K ﹤0.01%
+10
New +$57.8K
SPIL
2128
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
$79K ﹤0.01%
+10,031
New +$80K
ARWR icon
2129
Arrowhead Research
ARWR
$12.7B
$78K ﹤0.01%
+18,008
New +$42.9K
CETX icon
2130
Cemtrex
CETX
$5.03M
0
BDSI
2131
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$78K ﹤0.01%
+26,601
New +$81K
CPRX
2132
DELISTED
Catalyst Pharmaceutical
CPRX
$77K ﹤0.01%
+30,372
New +$83.3K
CRK icon
2133
Comstock Resources
CRK
$4.13B
$77K ﹤0.01%
+12,721
New +$82.7K
FRO icon
2134
Frontline
FRO
$8.36B
$77K ﹤0.01%
+12,764
New +$72K
NMTR
2135
DELISTED
9 Meters Biopharma
NMTR
$77K ﹤0.01%
+550
New +$86K
EGAN icon
2136
eGain
EGAN
$203M
$76K ﹤0.01%
+28,199
New +$54.9K
QMCO icon
2137
Quantum Corp
QMCO
$708M
$76K ﹤0.01%
+622
New +$83.4K
UAN icon
2138
CVR Partners
UAN
$1.25B
$76K ﹤0.01%
+2,354
New +$77.2K
TTPH
2139
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$76K ﹤0.01%
+552
New +$73.8K
GGN
2140
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$833M
$75K ﹤0.01%
+13,437
New +$75K
PIM
2141
Franklin Master Intermediate Income Trust
PIM
$153M
$75K ﹤0.01%
+15,864
New +$75K
TCON
2142
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$75K ﹤0.01%
+118
New +$61.5K
GV
2143
DELISTED
Goldfield Corporation
GV
$75K ﹤0.01%
+11,924
New +$60.7K
DNR
2144
DELISTED
Denbury Resources, Inc.
DNR
$75K ﹤0.01%
55,964
+41,259
+281% +$53.8K
LBCC
2145
DELISTED
Long Blockchain Corp. Common Stock
LBCC
$75K ﹤0.01%
+29,970
New +$116K
SRNE
2146
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$74K ﹤0.01%
43,348
+29,258
+208% +$53.7K
SPHS
2147
DELISTED
Sophiris Bio, Inc.
SPHS
$74K ﹤0.01%
+34,671
New +$71.8K
APT icon
2148
Alpha Pro Tech
APT
$54.9M
$73K ﹤0.01%
+19,060
New +$65.6K
FATE icon
2149
Fate Therapeutics
FATE
$318M
$73K ﹤0.01%
+18,493
New +$62.9K
TNDM icon
2150
Tandem Diabetes Care
TNDM
$1.62B
$73K ﹤0.01%
+9,957
New +$63K

Similar funds

Virtu Financial's Q3 2017 Portfolio in Review

As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,161 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 6.9% of assets, up from 5.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.

  • Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
  • Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
  • Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
  • Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
  • Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
  • Virtu Financial opened 2,161 new positions and closed 87 in Q3 2017.
  • Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.

Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.